Free Trial

Fortrea (FTRE) Competitors

Fortrea logo
$5.80 +1.14 (+24.46%)
Closing price 04:00 PM Eastern
Extended Trading
$5.75 -0.05 (-0.86%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FTRE vs. LFST, ARDT, NHC, TDOC, VRDN, GRAL, AHCO, AGL, PNTG, and AVAH

Should you be buying Fortrea stock or one of its competitors? The main competitors of Fortrea include LifeStance Health Group (LFST), Ardent Health (ARDT), National HealthCare (NHC), Teladoc Health (TDOC), Viridian Therapeutics (VRDN), GRAIL (GRAL), AdaptHealth (AHCO), Agilon Health (AGL), The Pennant Group (PNTG), and Aveanna Healthcare (AVAH). These companies are all part of the "healthcare" industry.

Fortrea vs. Its Competitors

LifeStance Health Group (NASDAQ:LFST) and Fortrea (NASDAQ:FTRE) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation.

LifeStance Health Group has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500. Comparatively, Fortrea has a beta of 1.76, meaning that its stock price is 76% more volatile than the S&P 500.

LifeStance Health Group has higher earnings, but lower revenue than Fortrea. LifeStance Health Group is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.25B1.31-$57.44M-$0.10-42.00
Fortrea$2.70B0.19-$328.50M-$8.79-0.66

LifeStance Health Group has a net margin of -2.78% compared to Fortrea's net margin of -29.43%. Fortrea's return on equity of 2.84% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group-2.78% -2.47% -1.69%
Fortrea -29.43%2.84%1.06%

LifeStance Health Group presently has a consensus target price of $8.50, indicating a potential upside of 102.38%. Fortrea has a consensus target price of $14.00, indicating a potential upside of 141.38%. Given Fortrea's higher possible upside, analysts plainly believe Fortrea is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.83
Fortrea
2 Sell rating(s)
12 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.86

In the previous week, Fortrea had 37 more articles in the media than LifeStance Health Group. MarketBeat recorded 43 mentions for Fortrea and 6 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.54 beat Fortrea's score of 0.03 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Fortrea
2 Very Positive mention(s)
2 Positive mention(s)
35 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Neutral

85.5% of LifeStance Health Group shares are owned by institutional investors. 6.6% of LifeStance Health Group shares are owned by insiders. Comparatively, 0.4% of Fortrea shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

LifeStance Health Group beats Fortrea on 10 of the 16 factors compared between the two stocks.

Get Fortrea News Delivered to You Automatically

Sign up to receive the latest news and ratings for FTRE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FTRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FTRE vs. The Competition

MetricFortreaMED IndustryMedical SectorNASDAQ Exchange
Market Cap$421.73M$2.96B$5.57B$9.41B
Dividend YieldN/A2.47%4.00%4.03%
P/E Ratio11.6520.5328.3219.89
Price / Sales0.19318.67446.45195.77
Price / Cash2.9640.8024.9928.17
Price / Book0.387.808.325.73
Net Income-$328.50M-$55.10M$3.24B$258.18M
7 Day Performance22.88%6.40%4.20%3.92%
1 Month Performance9.02%16.84%10.16%14.31%
1 Year Performance-78.37%3.12%34.69%17.29%

Fortrea Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FTRE
Fortrea
3.7446 of 5 stars
$5.80
+24.5%
$14.00
+141.4%
-82.1%$421.73M$2.70B11.6515,500Trending News
Gap Up
LFST
LifeStance Health Group
3.1115 of 5 stars
$4.17
-1.2%
$8.50
+103.8%
-24.2%$1.64B$1.25B-41.7010,218News Coverage
ARDT
Ardent Health
3.8325 of 5 stars
$10.93
-1.6%
$20.30
+85.8%
-36.8%$1.59B$5.97B6.7024,900
NHC
National HealthCare
N/A$97.31
-0.1%
N/A-21.8%$1.50B$1.37B12.1912,400News Coverage
TDOC
Teladoc Health
2.6375 of 5 stars
$8.34
+3.5%
$9.65
+15.8%
-8.3%$1.41B$2.57B-1.415,500News Coverage
VRDN
Viridian Therapeutics
3.2131 of 5 stars
$16.79
+1.6%
$37.56
+123.7%
+16.0%$1.35B$300K-4.3650
GRAL
GRAIL
0.5896 of 5 stars
$34.35
-2.4%
$31.50
-8.3%
+107.2%$1.27B$125.60M-0.561,360Positive News
AHCO
AdaptHealth
3.7467 of 5 stars
$9.15
-0.8%
$13.40
+46.4%
-14.0%$1.24B$3.26B16.0510,500Positive News
AGL
Agilon Health
2.7619 of 5 stars
$2.15
+1.2%
$4.71
+119.8%
-68.9%$877.58M$6.06B-3.641,076
PNTG
The Pennant Group
3.41 of 5 stars
$23.24
-0.8%
$33.80
+45.4%
-14.4%$807.61M$695.24M30.587,000
AVAH
Aveanna Healthcare
2.4284 of 5 stars
$4.03
+1.8%
$5.25
+30.3%
+17.2%$772.57M$2.02B201.5033,500News Coverage
Analyst Upgrade

Related Companies and Tools


This page (NASDAQ:FTRE) was last updated on 7/22/2025 by MarketBeat.com Staff
From Our Partners